IMVT
Immunovant, Inc. · Healthcare
CEO Peter Salzmann sold $258K of Immunovant, Inc.
Sold$257,888
$29.69Price
8,685Shares
−1%Stake
What IMVT did after the filing
- The stock from Fri, Jul 19 close, $27.97
- +10.5%
- S&P 500, same days
- +2.7%
Measured over 30 trading days, to the Aug 30 close.
Traded Wed, Jul 17. Filed Fri, Jul 19, 1:36 PM ET, during the session. Returns use the Jul 19 close and the Aug 30 close. Not investment advice.